Semaglutide versus other GLP-1 receptor agonists in patients with MASLD.

Hepatol Commun · 2025 · PMC12180814 · PMID 40536520

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the aHRs for MACE and MAKE were <1, these differences did not reach statistical significance (MACE: 21.5 vs. 22.0 events per 10,000 person-years; aHR, 0.96; 95% CI: 0.87–1.05; MAKE: 2.5 vs. 3.4 events per 10,000 person-years; aHR, 0.82; 95% CI: 0.63–1.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.